Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Behav Res Ther. 2020 Jun 29;132:103690. doi: 10.1016/j.brat.2020.103690

Table 2.

Pretreatment Means with Standard Deviations and Pretreatment Symptom Severity-Adjusted Means with Standard Deviations of Psychopathology Scores Between Racial Groups at Posttreatment (N = 173)

Measures Pre-treatment Post-treatment
African Americans (n = 43) Caucasians (n = 130) F d African Americans (n = 43) Caucasians (n = 130) F d
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
PE
 PTSD Severity (PSS-I) 28.71 (7.34) 29.76 (6.43) 0.68 0.14 9.58 (12.59) 11.07 (10.81) 0.54 0.13
 Depression (HRSD) 25.06 (12.86) 22.49 (9.42) 1.06 0.21 11.77 (12.93) 11.85 (11.25) 0.02 0.01
 Functioning (SDS) 18.71 (7.30) 18.43 (6.53) 0.17 0.03 8.98 (10.19) 11.10 (8.89) 0.95 0.22
Sertraline
 PTSD Severity (PSS-I) 30.79 (6.92) 29.28 (6.55) 0.85 0.20 13.67 (11.99) 12.61 (11.54) 0.32 0.09
 Depression (HRSD) 26.37 (11.43) 24.53 (10.17) 0.66 0.16 17.09 (12.16) 12.26 (11.46) 1.46 0.41
 Functioning (SDS) 19.26 (7.96) 19.90 (6.36) 0.35 0.08 12.99 (10.46) 10.97 (9.11) 0.73 0.21

Note. PE: Prolonged Exposure; PSS-I = PTSD Symptom Scale-Interview version; HRSD = Hamilton Rating Scale for Depression; SDS = Sheehan Disability Scale.